Novartis struck the deal to license the messenger RNA drug candidate and gain options over future therapies.
Novartis to License Drug From China’s Abogen in Up to $7.8 Billion Deal
Source: WSJ Technology
The Edge of the Cyber World See the latest
Novartis struck the deal to license the messenger RNA drug candidate and gain options over future therapies.
Source: WSJ Technology
